ARTICLE | Company News
Medinox sepsis deal with Fuso
May 10, 2000 7:00 AM UTC
Fuso (Osaka, Japan) received exclusive Japanese development and commercialization rights to Medinox's NOX-100 intravenous nitric oxide neutralizing compound to treat sepsis and one additional indicati...